연구동향 분석

Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay

허미나 Hee-Jung Chung Sumi Yoon Keumrock Hwang Hwan-Sub Lim 김한아 Hee-Won Moon Yeo-Min Yun 2020년

논문상세정보
인용/피인용
' Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Chronic myeloid leukemia
  • Droplet digital PCR
  • Performance
  • bcr-abl
  • evaluation
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,778 0

0.0%

' Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay' 의 참고문헌

  • User verification of precision and estimation of bias; approved guideline
    CLSI [2014]
  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia–a Europe against cancer program
    Gabert J [2003]
  • Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia
    Branford S [2006]
  • RT-qPCR and RT-digital PCR : a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia
    Alikian M [2017]
  • QXDx BCR-ABL %IS Kit. Instructions for use
  • QIAGEN ipsogen BCR-ABL1 Mbcr IS-MMR DX Kit Handbook
  • Optimized digital droplet PCR for BCR-ABL
    Maier J [2019]
  • Measurement procedure comparison and bias estimation using patients; approved guideline
    CLSI [2013]
  • Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
    Cross NC [2015]
  • Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline
    CLSI [2003]
  • Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline
    CLSI [2012]
  • Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)–a Europe against cancer program
    Beillard E [2003]
  • Droplet digital PCR for BCR/ABL (P210) detection of chronic myeloid leukemia: a high sensitive method of the minimal residual disease and disease progression
    Wang WJ [2018]
  • Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
    Kong JH [2017]
  • Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR
    Jennings LJ [2014]
  • Considerations for digital PCR as an accurate molecular diagnostic tool
    Huggett JF [2015]
  • Chronic Myeloid Leukemia, Version 1. 2019, NCCN clinical practice guidelines in oncology
    Radich JP [2018]
  • A review of the European LeukemiaNet recommendations for the management of CML
    Baccarani M [2015]